Of these, 2876 (42.3%; 37.3% female) were in the T2D-MDI cohort and 2292 (33.7%; 38.3% female) were in the T2D-B cohort; 1632 individuals with type 2 diabetes with at least one registration of isCGM were not on either multiple daily injections or basal insulin therapy and were not included in the analysis. Here, INS is linked to type 2 diabetes mellitus.